Best Practice & Research Clinical Anaesthesiology
Volume 23, Issue 2 , Pages 183-191 , June 2009

Relevance of albumin in modern critical care medicine

  • Jean-Louis Vincent, MD, PhD (Professor and Head of the Department)

      Affiliations

    • Corresponding Author InformationDepartment of Intensive Care, Erasme Hospital, Route de lennik 808, 1070 Bruxelles, Belgium. Tel.: +32 2 555 3380; Fax: +32 2 555 4555.

References 

  1. Cochrane Injuries Group . Human albumin administration in critically ill patients: systematic review of randomized controlled trials. BMJ (Clinical Research Ed.). 1998;317:235–240
  2. Wilkes MM, Navickis RJ. Patient survival after human albumin administration. A meta-analysis of randomized, controlled trials. Annals of Internal Medicine. 2001;135:149–164
  3. Finfer S, Bellomo R, Boyce N, et al. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. The New England Journal of Medicine. 2004;350:2247–2256
  4. Quinlan GJ, Martin GS, Evans TW. Albumin: biochemical properties and therapeutic potential. Hepatology. 2005;41:1211–1219
  5. Masuoka J, Saltman P. Zinc(II) and copper(II) binding to serum albumin. A comparative study of dog, bovine, and human albumin. The Journal of Biological Chemistry. 1994;269:25557–25561
  6. Spector AA. Fatty acid binding to plasma albumin. Journal of Lipid Research. 1975;16:165–179
  7. Cooke JR, Roberts LB. The binding of bilirubin to serum proteins. Clinica Chimica Acta; International Journal of Clinical Chemistry. 1969;26:425–436
  8. Stamler JS, Jaraki O, Osborne J, et al. Nitric oxide circulates in mammalian plasma primarily as an S-nitroso adduct of serum albumin. Proceedings of the National Academy of Sciences of the United States of America. 1992;89:7674–7677
  9. Roche M, Rondeau P, Singh NR, et al. The antioxidant properties of serum albumin. FEBS Letters. 2008;582:1783–1787
  10. Joorgensen KA, Stoffersen E. Heparin like activity of albumin. Thrombosis Research. 1979;16:569–574
  11. Grigoriadis G, Stewart AG. Albumin inhibits platelet-activating factor (PAF)-induced responses in platelets and macrophages: implications for the biologically active form of PAF. British Journal of Pharmacology. 1992;107:73–77
  12. Jorgensen KA, Stoffersen E. On the inhibitory effect of albumin on platelet aggregation. Thrombosis Research. 1980;17:13–18
  13. Zoellner H, Hofler M, Beckmann R, et al. Serum albumin is a specific inhibitor of apoptosis in human endothelial cells. Journal of Cell Science. 1996;109(Pt 10):2571–2580
  14. Moshage HJ, Janssen JA, Franssen JH, et al. Study of the molecular mechanism of decreased liver synthesis of albumin in inflammation. The Journal of Clinical Investigation. 1987;79:1635–1641
  15. Brenner DA, Buck M, Feitelberg SP, Chojkier M. Tumor necrosis factor-alpha inhibits albumin gene expression in a murine model of cachexia. The Journal of Clinical Investigation. 1990;85:248–255
  16. Fleck A, Raines G, Hawker F, et al. Increased vascular permeability: a major cause of hypoalbuminemia in disease and injury. Lancet. 1985;1:781–783
  17. Goldwasser P, Feldman J. Association of serum albumin and mortality risk. Journal of Clinical Epidemiology. 1997;50:693–703
  18. Kaysen GA, Johansen KL, Cheng SC, et al. Trends and outcomes associated with serum albumin concentration among incident dialysis patients in the United States. Journal of Renal Nutrition. 2008;18:323–331
  19. Horwich TB, Kalantar-Zadeh K, MacLellan RW, Fonarow GC. Albumin levels predict survival in patients with systolic heart failure. American Heart Journal. 2008;155:883–889
  20. Ryan AM, Hearty A, Prichard RS, et al. Association of hypoalbuminemia on the first postoperative day and complications following esophagectomy. Journal of Gastrointestinal Surgery. 2007;11:1355–1360
  21. Schirmer-Mikalsen K, Vik A, Gisvold SE, et al. Severe head injury: control of physiological variables, organ failure and complications in the intensive care unit. Acta Anaesthesiologica Scandinavica. 2007;51:1194–1201
  22. Tung CF, Chow WK, Chang CS, et al. The prevalence and significance of hypoalbuminemia in non-variceal upper gastrointestinal bleeding. Hepatogastroenterology. 2007;54:1153–1156
  23. Fritz HG, Brandes H, Bredle DL, et al. Post-operative hypoalbuminaemia and procalcitonin elevation for prediction of outcome in cardiopulmonary bypass surgery. Acta Anaesthesiologica Scandinavica. 2003;47:1276–1283
  24. Herrmann FR, Safran C, Levkoff SE, Minaker KL. Serum albumin level on admission as a predictor of death, length of stay, and readmission. Archives of Internal Medicine. 1992;152:125–130
  25. McCluskey A, Thomas AN, Bowles BJ, Kishen R. The prognostic value of serial measurements of serum albumin concentration in patients admitted to an intensive care unit. Anaesthesia. 1996;51:724–727
  26. Finfer S, Bellomo R, McEvoy M, et al. Effect of baseline serum albumin concentration on outcome of resuscitation with albumin or saline in patients in intensive care units: analysis of data from the Saline versus Albumin Fluid Evaluation (SAFE) Study. BMJ (Clinical Research Ed.). 2006;333:1044
  27. Sullivan DH, Roberson PK, Bopp MM. Hypoalbuminemia 3 months after hospital discharge: significance for long-term survival. Journal of the American Geriatrics Society. 2005;53:1222–1226
  28. Vincent JL, Dubois MJ, Navickis RJ, Wilkes MM. Hypoalbuminemia in acute illness: is there a rationale for intervention? A meta-analysis of cohort studies and controlled trials. Annals of Surgery. 2003;237:319–334
  29. Vincent JL, Wilkes MM, Navickis RJ. Safety of human albumin: serious adverse events reported worldwide in 1998–2000. British Journal of Anaesthesia. 2003;91:625–630
  30. Boldt J. The good, the bad, and the ugly: should we completely banish human albumin from our intensive care units?. Anesthesia and Analgesia. 2000;91:887–895table
  31. Vincent JL, Sakr Y, Reinhart K, et al. Is albumin administration in the acutely ill associated with increased mortality? Results of the SOAP study. Critical Care (London, England). 2005;9:R745–R754
  32. Martin GS, Moss M, Wheeler AP, et al. A randomized, controlled trial of furosemide with or without albumin in hypoproteinemic patients with acute lung injury. Critical Care Medicine. 2005;33:1681–1687
  33. Vincent JL. Resuscitation using albumin in critically ill patients: research in patients at high risk of complications is now needed. BMJ (Clinical Research Ed.). 2006;333:1029–1030
  34. Dubois MJ, Orellana-Jimenez C, Melot C, et al. Albumin administration improves organ function in critically ill hypoalbuminemic patients: A prospective, randomized, controlled, pilot study. Critical Care Medicine. 2006;34:2536–2540
  35. Sort P, Navasa M, Arroyo V, et al. Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. The New England Journal of Medicine. 1999;341:403–409
  36. Fernandez J, Monteagudo J, Bargallo X, et al. A randomized unblinded pilot study comparing albumin versus hydroxyethyl starch in spontaneous bacterial peritonitis. Hepatology. 2005;42:627–634
  37. Ortega R, Gines P, Uriz J, et al. Terlipressin therapy with and without albumin for patients with hepatorenal syndrome: results of a prospective, nonrandomized study. Hepatology. 2002;36:941–948
  38. Salerno F, Gerbes A, Gines P, et al. Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis. Gut. 2007;56:1310–1318
  39. Myburgh J, Cooper J, Finfer S, et al. Saline or albumin for fluid resuscitation in patients with traumatic brain injury. The New England Journal of Medicine. 2007;357:874–884

PII: S1521-6896(08)00101-8

doi: 10.1016/j.bpa.2008.11.004

Best Practice & Research Clinical Anaesthesiology
Volume 23, Issue 2 , Pages 183-191 , June 2009

Article Tools

* Image Usage & Resolution